<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01227317</url>
  </required_header>
  <id_info>
    <org_study_id>BIODINER BRAHMS France</org_study_id>
    <nct_id>NCT01227317</nct_id>
  </id_info>
  <brief_title>BIOmarkers of Dyspnea IN Emergency Room</brief_title>
  <acronym>BIODINER</acronym>
  <official_title>Prognostic Value of Novel Biomarkers in Patients With Shortness of Breath Attending an Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ThermoFisher Scientific Brahms Biomarkers France</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ThermoFisher Scientific Brahms Biomarkers France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the capacity of some novels biomarkers Procalcitonin
      (PCT), Midregional Proadrenomedullin (MR pro ADM), Midregional pro-atrial natriuretic peptide
      (MR pro ANP), Copeptin (CT pro arginine vasopressin), Pro endothelin to stratify the risk in
      severe dyspnea.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In emergency department shortness of breath (SOB)is a common symptom and its cause is not
      easy to be identified. The risk stratifying remains a challenge, Prognostic value of
      biomarkers might be helpful.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>prognostic value of PCT, MR proADM, Mr pro ANP, Copeptin and pro endothelin in SOB</measure>
    <time_frame>at Day 30</time_frame>
    <description>all cause mortality or Intensive Care Unit(ICU) admission from inclusion to Day 30</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>establish the diagnostic value of PCT and MR pro ANP</measure>
    <time_frame>at admission</time_frame>
    <description>Confirm the diagnostic value of PCT and it's level in sepsis and MR pro ANP in Heart failure</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">444</enrollment>
  <condition>Severe Dyspnea</condition>
  <condition>CAPD</condition>
  <condition>AE COPD</condition>
  <condition>Acute Heart Failure</condition>
  <condition>Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>Acute dyspnea in ED</arm_group_label>
    <description>Acute severe shortness of breath (SOB) in emergency Department (ED) with suspicion of acute heart failure (AHF) or Pulmonary Embolism (PE)or Community-acquired pneumonia (CAP) or acute Exacerbation of chronic obstructive pulmonary disease (AE COPD)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prognostic value of Biomarkers</intervention_name>
    <description>Mr pro ADM, Mr pro ANP, PCT, Copeptin and pro endothelin value to stratify the risk in SOB patients</description>
    <arm_group_label>Acute dyspnea in ED</arm_group_label>
    <other_name>Dyspnea</other_name>
    <other_name>Prognostic value</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Severe acute SOB Suspicion of CAP, Acute Heart failure, AE COPD or PE
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  tachypnea &gt; 25 /min or Pa02 &lt; 70 mmHg or SpO2 &lt; 93%

          -  diagnosis suspected: CAP, PE,EACOPD, AHF

        Exclusion Criteria:

          -  other cause of dyspnea,

          -  unreachable on Day 30
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Hausfater, Pr</last_name>
    <role>Study Chair</role>
    <affiliation>ED Pitié SalpêtrièreHospital in Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yann-Erick Claessens, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>ED Cochin Hospital in Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guillaume Der Sahakian, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>ED Hotel Dieu Hospital in Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arnaud Martinage, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>ED Hotel Dieu Hospital in Nantes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fatima Rayeh, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>ED La Miletrie Hospital in Poitiers</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eric Weil, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>ED Hospital B in Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luc-Marie JOLY, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>ED Charles Nicolle Hospital in Rouen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emergency department of Pitié Salpetriere Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2010</study_first_submitted>
  <study_first_submitted_qc>October 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2010</study_first_posted>
  <last_update_submitted>December 6, 2011</last_update_submitted>
  <last_update_submitted_qc>December 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dyspnea</keyword>
  <keyword>Mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Dyspnea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

